Stoke Therapeutics (STOK) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order at 9:00 A.M. Eastern Time on June 3rd, 2026, with a virtual format to increase inclusivity and participation.

• Board members, corporate officers, legal counsel, and independent accountants were introduced.

• The agenda included formal business matters, voting on proposals, and a Q&A session at the end.

Corporate governance

• The record date for voting was set as April 7th, 2026, with notice and proxy materials mailed to eligible stockholders.

• A quorum was established with 88.6% of shares represented, allowing the meeting to proceed.

Overview of voting outcomes

• Three proposals were presented: election of directors, ratification of the accounting firm, and advisory approval of executive compensation.

• G. Clare Kahn, Adrian Krainer, and Julie Anne Smith were elected as Class I directors for three-year terms.

• Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31st, 2026.

• Executive compensation was approved on an advisory basis by a majority vote.